Skip to main content

Zai Lab

Zai Lab Ltd is a biopharmaceutical enterprise headquartered in Shanghai, China, and Cambridge, Massachusetts. The company focuses on the discovery, development, and commercialization of innovative oncology, autoimmune, infectious, and neuroscience therapeutics, licensing and partnering advanced drug candidates for the Chinese and global markets. Principal revenue is derived through commercial pharmaceutical product sales of approved specialty medications and collaborative research licensing agreements. Zai Lab Ltd is publicly listed on the Nasdaq Stock Market and the Hong Kong Stock Exchange.

4 of the funds FundTelligence covers report a position in Zai Lab.

Legal name
Zai Lab Ltd
Sector
Health Care
Country
China
Funds holding it
4

Funds holding Zai Lab

Loading...